机器人辅助腔镜甲状腺手术在中国的发展和现状

The development and current situation of robot-assisted endoscopic thyroid surgery in China

机器人手术系统于2007年首次应用于甲状腺手术,其整合了腔镜与传统开放手术的优点,进一步促进了甲状腺微创外科的发展。2014年,笔者单位首先在国内开展机器人甲状腺手术,并为3200余例患者成功实施手术,截至2023年7月国内共完成11931例机器人甲状腺手术。其美容效果明显优于传统开放手术,且常用入路的操作及肿瘤学安全性数据也随着开展数量及质量的提高而得到更新,为国内机器人甲状腺手术的开展,提供了经验指导。新技术的发展及临床应用,也同样促进了国产机器人的研发与实践。未来,将会有更多国产机器人投入临床,进一步降低手术成本,使其像腔镜技术一样得以在临床普及。在此,笔者对相关情况作一概述,以便国内同行进一步了解其在中国的发展和现状。

The robotic surgery system was first applied to thyroid surgery in 2007,which integrates the advantages of endoscopic and traditional open surgery,and further promotes the development of minimally invasive thyroid surgery.In 2014,our institution pioneered robotic thyroid surgery in China,successfully performing surgeries for over 3200 patients.As of July this year,a total of 11931 robotic thyroid surgeries have been completed nationwide.Its cosmetic results are significantly superior to traditional open surgery,and the safety data for commonly used approaches and oncological safety data have been continually updated with the improvement in both quantity and quality of operations.This has provided valuable experiential guidance for the implementation of robotic thyroid surgery in China.The development and clinical application of new technologies have also similarly promoted the research and practice of domestic robots.In the future,more locally produced robots will be put into clinical use,leading to a further reduction in surgical costs and facilitating their widespread adoption in clinical practice,similar to the popularity of endoscopic techniques.Here,the authors provide a overview of the relevant information in respect of its development and current status in China,so as to aid a better understanding for fellow professionals.